← Leaderboards
Val S. Goodfellow
Califia Bio, Inc.
$1,382,230
Attributed
$2,458,563
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $831.5K · FY2011–15$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,458,563 · 5
By mechanism
R44$1,761,170 · 2
R43$697,393 · 3
Top collaborators
- Harris A Gelbard3 shared
- Stephen Dewhurst2 shared
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantPropertyDoseInhibitor/AntagonistStructurePhosphotransferasesAnimal ModelIn VitroBaseSmall MoleculeCellsIntellectual PropertyIn VivoInflammationPreventLeadPathway InteractionsSeriesUniversitiesIn Vitro AssayIn Vitro ActivityCollaborationsIn Vivo ModelGrant
Grant awards (6)
MLKi Therapy for Cognitive Impairment in Multiple Sclerosis$586,679
R44 · FY2015 · NS · contact PI
Inhibition of HIV-Induced Synaptodentritic Damage$607,680
R44 · FY2014 · MH · contact PI
CLFB143 Analogs to Treat Glaucoma$223,800
R43 · FY2014 · EY · contact PI
Inhibition of HIV-Induced Synaptodentritic Damage$566,811
R44 · FY2013 · MH · contact PI
Non-Type I Kinase Inhibition of HIV-Induced Synaptodendritic Damage/Leukocyte Inf$255,293
R43 · FY2011 · MH · contact PI
Therapeutic Small Molecule Modulators of G beta gama Signaling$218,300
R43 · FY2011 · HL · contact PI